Michael D. Dale, Chief Executive Officer at ATS MEDICAL INC (ATSI), sold 4,220 shares at $2.79 ($12K) on 2009-01-12, disclosed to the SEC on 2009-01-13.
Scheduled sale ($12k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABT | SELL | 2023-03-02 | $243K | — | Filing → |
| ABT | SELL | 2022-03-10 | $468K | — | Filing → |
| ABT | SELL | 2022-03-02 | $249K | — | Filing → |